Helping Patients Regain Sight

LambdaVision is developing the first protein-based artificial retina to restore meaningful vision for patients who are blind or have lost significant sight due to advanced retinal degenerative diseases, including retinitis pigmentosa (RP) and age-related macular degeneration (AMD).

Both RP and AMD lead to the breakdown and loss of cells in the retina. By using proteins similar to the visual pigment rhodopsin that is naturally found in our eyes, LambdaVision’s protein-based artificial retina mimics the light-absorbing properties of human photoreceptors replacing the function of these damaged cells in the retinas of blind patients.

In The Media

LambdaVision Announces First Closing of Seed Round to Advance Artificial Retina Preclinical Studies for Retinal Eye Diseases

Drug Companies Explore Making Some of Their Most Lucrative Drugs in Space

Nicole Wagner Wants to Help People Regain Vision

Women’s History Month: 25 Revolutionary Women in Science and Biotech

TIP Startup LambdaVision Brings Promising Microgravity Manufacturing Experiments Back to Earth

Astronauts to Help Build Artificial Retinas on Space Station

Skip to content